{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:27:59Z","timestamp":1792211279996,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04732-8","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:36:54Z","timestamp":1733510214000},"page":"2522-2532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Classification of intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Maria","family":"El Homsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alkhasawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Arif-Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Czeyda-Pommersheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Khasawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Siobhan","family":"Kierans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Mohan","family":"Paspulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"issue":"Suppl 1","key":"4732_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39 Suppl 1:19\u201331. doi: https:\/\/doi.org\/10.1111\/liv.14095.","journal-title":"Liver Int"},{"issue":"6","key":"4732_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215\u201329. doi: https:\/\/doi.org\/10.1053\/j.gastro.2013.10.013.","journal-title":"Gastroenterology"},{"issue":"1","key":"4732_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cncr.29686","volume":"122","author":"Y Sakamoto","year":"2016","unstructured":"Sakamoto Y, Kokudo N, Matsuyama Y, Sakamoto M, Izumi N, Kadoya M, et al. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer. 2016;122(1):61\u201370. doi: https:\/\/doi.org\/10.1002\/cncr.29686.","journal-title":"Cancer"},{"issue":"5","key":"4732_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.5858\/arpa.2020-0047-RA","volume":"145","author":"RS Gonzalez","year":"2021","unstructured":"Gonzalez RS, Raza A, Propst R, Adeyi O, Bateman J, Sopha SC, et al. Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization \u201cBlue Book\u201d. Archives of pathology & laboratory medicine. 2021;145(5):607\u201326. doi: https:\/\/doi.org\/10.5858\/arpa.2020-0047-RA.","journal-title":"Archives of pathology & laboratory medicine"},{"key":"4732_CR5","doi-asserted-by":"publisher","unstructured":"Lo JH, Agarwal R, Goff LW, Heumann TR. Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies. Cancers (Basel). 2023;15(13). doi: https:\/\/doi.org\/10.3390\/cancers15133312.","DOI":"10.3390\/cancers15133312"},{"issue":"1","key":"4732_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib PL, Goodchild G, Pereira SP. Molecular Pathogenesis of Cholangiocarcinoma. BMC cancer. 2019;19(1):185. doi: https:\/\/doi.org\/10.1186\/s12885-019-5391-0.","journal-title":"BMC cancer"},{"key":"4732_CR7","doi-asserted-by":"publisher","first-page":"1389289","DOI":"10.1155\/2019\/1389289","volume":"2019","author":"T Hucl","year":"2019","unstructured":"Hucl T. Precursors to Cholangiocarcinoma. Gastroenterol Res Pract. 2019;2019:1389289. doi: https:\/\/doi.org\/10.1155\/2019\/1389289.","journal-title":"Gastroenterol Res Pract"},{"key":"4732_CR8","doi-asserted-by":"publisher","unstructured":"Nakanuma Y, Kakuda Y, Sugino T, Sato Y, Fukumura Y. Pathologies of Precursor Lesions of Biliary Tract Carcinoma. Cancers (Basel). 2022;14(21). doi: https:\/\/doi.org\/10.3390\/cancers14215358.","DOI":"10.3390\/cancers14215358"},{"issue":"1","key":"4732_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2214\/ajr.17.19261","volume":"211","author":"HJ Park","year":"2018","unstructured":"Park HJ, Kim SY, Kim HJ, Lee SS, Hong GS, Byun JH, et al. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features. AJR Am J Roentgenol. 2018;211(1):67\u201375. doi: https:\/\/doi.org\/10.2214\/ajr.17.19261.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"4732_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2214\/ajr.20.22768","volume":"216","author":"JH Boyum","year":"2021","unstructured":"Boyum JH, Sheedy SP, Graham RP, Olson JT, Babcock AT, Bolan CW, et al. Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI. AJR Am J Roentgenol. 2021;216(2):403\u201311. doi: https:\/\/doi.org\/10.2214\/ajr.20.22768.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"4732_CR11","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1148\/rg.2021210011","volume":"41","author":"MH Lee","year":"2021","unstructured":"Lee MH, Katabathina VS, Lubner MG, Shah HU, Prasad SR, Matkowskyj KA, Pickhardt PJ. Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features. Radiographics. 2021;41(6):1592\u2013610. doi: https:\/\/doi.org\/10.1148\/rg.2021210011.","journal-title":"Radiographics"},{"issue":"5","key":"4732_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755\u201362. doi: https:\/\/doi.org\/10.1097\/01.sla.0000251366.62632.d3.","journal-title":"Ann Surg"},{"issue":"4","key":"4732_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","volume":"224","author":"A Nakeeb","year":"1996","unstructured":"Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463\u201373; discussion 73\u2013\u20095. doi: https:\/\/doi.org\/10.1097\/00000658-199610000-00005.","journal-title":"Ann Surg"},{"issue":"1","key":"4732_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","volume":"6","author":"S Vijgen","year":"2017","unstructured":"Vijgen S, Terris B, Rubbia-Brandt L. Pathology of intrahepatic cholangiocarcinoma. Hepatobiliary surgery and nutrition. 2017;6(1):22\u201334. doi: https:\/\/doi.org\/10.21037\/hbsn.2016.11.04.","journal-title":"Hepatobiliary surgery and nutrition"},{"key":"4732_CR15","first-page":"606","volume":"11","author":"C-N Yeh","year":"2004","unstructured":"Yeh C-N, Jan Y-Y, Yeh T-S, Hwang T-L, Chen M-FJAoso. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. 2004;11:606\u201311.","journal-title":"Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma"},{"issue":"3","key":"4732_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1478-3231.2011.02640.x","volume":"32","author":"HT Jeong","year":"2012","unstructured":"Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS. MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int. 2012;32(3):430\u201340. doi: https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02640.x.","journal-title":"Liver Int"},{"issue":"9","key":"4732_CR17","first-page":"1206","volume":"85","author":"A Sasaki","year":"1998","unstructured":"Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T, Kitano SJJoBS. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. 1998;85(9):1206\u20139.","journal-title":"Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment"},{"issue":"5","key":"4732_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00261-004-0187-2","volume":"29","author":"JH Lim","year":"2004","unstructured":"Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdominal imaging. 2004;29(5):540\u20137. doi: https:\/\/doi.org\/10.1007\/s00261-004-0187-2.","journal-title":"Abdominal imaging"},{"issue":"2","key":"4732_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/hbsn.2016.12.10","volume":"6","author":"K F\u00e1brega-Foster","year":"2017","unstructured":"F\u00e1brega-Foster K, Ghasabeh MA, Pawlik TM, Kamel IR. Multimodality imaging of intrahepatic cholangiocarcinoma. Hepatobiliary surgery and nutrition. 2017;6(2):67\u201378. doi: https:\/\/doi.org\/10.21037\/hbsn.2016.12.10.","journal-title":"Hepatobiliary surgery and nutrition"},{"issue":"2","key":"4732_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2004-828892","volume":"24","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):155\u201364. doi: https:\/\/doi.org\/10.1055\/s-2004-828892.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"4732_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00261-013-0021-9","volume":"38","author":"JR Ayuso","year":"2013","unstructured":"Ayuso JR, Pag\u00e9s M, Darnell A. Imaging bile duct tumors: staging. Abdominal imaging. 2013;38(5):1071\u201381. doi: https:\/\/doi.org\/10.1007\/s00261-013-0021-9.","journal-title":"Abdominal imaging"},{"key":"4732_CR22","doi-asserted-by":"publisher","unstructured":"Gore RM, Shelhamer RP. Biliary tract neoplasms: diagnosis and staging. Cancer imaging: the official publication of the International Cancer Imaging Society. 2007;7 Spec No A(Special issue A):S15-23. doi: https:\/\/doi.org\/10.1102\/1470-7330.2007.9016.","DOI":"10.1102\/1470-7330.2007.9016"},{"issue":"1","key":"4732_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma","year":"2023","unstructured":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79(1):181\u2013208. doi: https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010.","journal-title":"J Hepatol"},{"issue":"3","key":"4732_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","volume":"181","author":"JH Lim","year":"2003","unstructured":"Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR American journal of roentgenology. 2003;181(3):819\u201327. doi: https:\/\/doi.org\/10.2214\/ajr.181.3.1810819.","journal-title":"AJR American journal of roentgenology"},{"key":"4732_CR25","first-page":"288","volume":"10","author":"Yamasaki SJJoh-b-ps","year":"2003","unstructured":"Yamasaki SJJoh-b-ps. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. 2003;10:288\u201391.","journal-title":"Intrahepatic cholangiocarcinoma: macroscopic type and stage classification"},{"issue":"7","key":"4732_CR26","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/modpathol.2017.22","volume":"30","author":"M Akita","year":"2017","unstructured":"Akita M, Fujikura K, Ajiki T, Fukumoto T, Otani K, Azuma T, et al. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2017;30(7):986\u201397. doi: https:\/\/doi.org\/10.1038\/modpathol.2017.22.","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"8","key":"4732_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","volume":"27","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2014;27(8):1163\u201373. doi: https:\/\/doi.org\/10.1038\/modpathol.2013.241.","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc."},{"issue":"10","key":"4732_CR28","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/pas.0000000000001118","volume":"42","author":"CS Sigel","year":"2018","unstructured":"Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, et al. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns. Am J Surg Pathol. 2018;42(10):1334\u201345. doi: https:\/\/doi.org\/10.1097\/pas.0000000000001118.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4732_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/liv.13492","volume":"38","author":"H Rhee","year":"2018","unstructured":"Rhee H, Ko JE, Chung T, Jee BA, Kwon SM, Nahm JH, et al. Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma. Liver Int. 2018;38(1):113\u201324. doi: https:\/\/doi.org\/10.1111\/liv.13492.","journal-title":"Liver Int"},{"key":"4732_CR30","doi-asserted-by":"publisher","unstructured":"Komuta M. Histological Heterogeneity of Primary Liver Cancers: Clinical Relevance, Diagnostic Pitfalls and the Pathologist\u2019s Role. Cancers (Basel). 2021;13(12). doi: https:\/\/doi.org\/10.3390\/cancers13122871.","DOI":"10.3390\/cancers13122871"},{"issue":"6","key":"4732_CR31","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/hep.25595","volume":"55","author":"M Komuta","year":"2012","unstructured":"Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012;55(6):1876\u201388. doi: https:\/\/doi.org\/10.1002\/hep.25595.","journal-title":"Hepatology"},{"issue":"2","key":"4732_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. doi: https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4732_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40644-023-00533-2","volume":"23","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Zhou C, Ni X, Huang P, Wu F, Yang C, Zeng M. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma. Cancer imaging: the official publication of the International Cancer Imaging Society. 2023;23(1):15. doi: https:\/\/doi.org\/10.1186\/s40644-023-00533-2.","journal-title":"Cancer imaging: the official publication of the International Cancer Imaging Society"},{"issue":"3","key":"4732_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000521747","volume":"11","author":"S Park","year":"2022","unstructured":"Park S, Lee Y, Kim H, Yu MH, Lee ES, Yoon JH, et al. Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value. Liver Cancer. 2022;11(3):233\u201346. doi: https:\/\/doi.org\/10.1159\/000521747.","journal-title":"Liver Cancer"},{"issue":"1","key":"4732_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","volume":"73","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Barriuso J, McNamara MG, Valle JW. Molecular targeted therapies: Ready for \u201cprime time\u201d in biliary tract cancer. J Hepatol. 2020;73(1):170\u201385. doi: https:\/\/doi.org\/10.1016\/j.jhep.2020.03.007.","journal-title":"J Hepatol"},{"issue":"9","key":"4732_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.Cd-17-0245","volume":"7","author":"JW Valle","year":"2017","unstructured":"Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX. New Horizons for Precision Medicine in Biliary Tract Cancers. Cancer discovery. 2017;7(9):943\u201362. doi: https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0245.","journal-title":"Cancer discovery"},{"issue":"3","key":"4732_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","volume":"19","author":"JS Ross","year":"2014","unstructured":"Ross JS, Wang K, Gay L, Al-Rohil R, Rand JV, Jones DM, et al. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. The oncologist. 2014;19(3):235\u201342. doi: https:\/\/doi.org\/10.1634\/theoncologist.2013-0352.","journal-title":"The oncologist"},{"issue":"6","key":"4732_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ng.2273","volume":"44","author":"CK Ong","year":"2012","unstructured":"Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nature genetics. 2012;44(6):690\u20133. doi: https:\/\/doi.org\/10.1038\/ng.2273.","journal-title":"Nature genetics"},{"issue":"2","key":"4732_CR39","doi-asserted-by":"publisher","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","volume":"10","author":"MJ Borad","year":"2014","unstructured":"Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. PLoS genetics. 2014;10(2):e1004135. doi: https:\/\/doi.org\/10.1371\/journal.pgen.1004135.","journal-title":"PLoS genetics"},{"issue":"8","key":"4732_CR40","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/s1470-2045(15)00139-4","volume":"16","author":"JW Valle","year":"2015","unstructured":"Valle JW, Wasan H, Lopes A, Backen AC, Palmer DH, Morris K, et al. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. Lancet Oncol. 2015;16(8):967\u201378. doi: https:\/\/doi.org\/10.1016\/s1470-2045(15)00139-4.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"4732_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, Carpino G. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39 Suppl 1:7\u201318. doi: https:\/\/doi.org\/10.1111\/liv.14093.","journal-title":"Liver Int"},{"issue":"10","key":"4732_CR42","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.hpb.2022.05.1341","volume":"24","author":"E Buckarma","year":"2022","unstructured":"Buckarma E, De La Cruz G, Truty M, Nagorney D, Cleary S, Kendrick M, et al. Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2022;24(10):1748\u201356. doi: https:\/\/doi.org\/10.1016\/j.hpb.2022.05.1341.","journal-title":"HPB: the official journal of the International Hepato Pancreato Biliary Association"},{"issue":"5","key":"4732_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11523-022-00906-w","volume":"17","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Bibeau K, Schultz N, Yaqubie A, Millang B, Ren H, F\u00e9liz L. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma. Targeted oncology. 2022;17(5):517\u201327. doi: https:\/\/doi.org\/10.1007\/s11523-022-00906-w.","journal-title":"Targeted oncology"},{"issue":"1","key":"4732_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12885-020-06804-6","volume":"20","author":"B Ma","year":"2020","unstructured":"Ma B, Meng H, Tian Y, Wang Y, Song T, Zhang T, et al. Distinct clinical and prognostic implication of IDH1\/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma. BMC cancer. 2020;20(1):318. doi: https:\/\/doi.org\/10.1186\/s12885-020-06804-6.","journal-title":"BMC cancer"},{"issue":"25","key":"4732_CR45","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/onc.2012.315","volume":"32","author":"P Wang","year":"2013","unstructured":"Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, Jeck WR, et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene. 2013;32(25):3091\u2013100. doi: https:\/\/doi.org\/10.1038\/onc.2012.315.","journal-title":"Oncogene"},{"issue":"11","key":"4732_CR46","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","volume":"36","author":"Y Nakanuma","year":"2012","unstructured":"Nakanuma Y, Sato Y, Ikeda H, Harada K, Kobayashi M, Sano K, et al. Intrahepatic cholangiocarcinoma with predominant \u201cductal plate malformation\u201d pattern: a new subtype. Am J Surg Pathol. 2012;36(11):1629\u201335. doi: https:\/\/doi.org\/10.1097\/PAS.0b013e31826e0249.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4732_CR47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5009\/gnl210174","volume":"16","author":"T Chung","year":"2022","unstructured":"Chung T, Rhee H, Shim HS, Yoo JE, Choi GH, Kim H, Park YN. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut Liver. 2022;16(4):613\u201324. doi: https:\/\/doi.org\/10.5009\/gnl210174.","journal-title":"Gut Liver"},{"issue":"10","key":"4732_CR48","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/pas.0000000000001716","volume":"45","author":"JH Tsai","year":"2021","unstructured":"Tsai JH, Liau JY, Lee CH, Jeng YM. Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT\/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection. Am J Surg Pathol. 2021;45(10):1409\u201318. doi: https:\/\/doi.org\/10.1097\/pas.0000000000001716.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4732_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/PAS.0b013e31802c0c8a","volume":"31","author":"S Haas","year":"2007","unstructured":"Haas S, G\u00fctgemann I, Wolff M, Fischer HP. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma. Am J Surg Pathol. 2007;31(6):902\u20136. doi: https:\/\/doi.org\/10.1097\/PAS.0b013e31802c0c8a.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4732_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.21147\/j.issn.1000-9604.2018.03.08","volume":"30","author":"Z Li","year":"2018","unstructured":"Li Z, Wu X, Bi X, Zhang Y, Huang Z, Lu H, et al. Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma. Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu. 2018;30(3):364\u201372. doi: https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2018.03.08.","journal-title":"Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu"},{"key":"4732_CR51","doi-asserted-by":"publisher","unstructured":"van Weert S, Lissenberg-Witte BI, Bloemena E, Leemans CR. Mucoepidermoid carcinoma of the head and neck: CRTC1\/3 MAML 2 translocation and its prognosticators. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2022;279(5):2573\u201381. doi: https:\/\/doi.org\/10.1007\/s00405-021-07039-2.","DOI":"10.1007\/s00405-021-07039-2"},{"issue":"1","key":"4732_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13000-019-0863-8","volume":"14","author":"J Watanabe","year":"2019","unstructured":"Watanabe J, Kai K, Tanikawa K, Hiraki M, Mizukami N, Aishima S, et al. Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report. Diagnostic pathology. 2019;14(1):84. doi: https:\/\/doi.org\/10.1186\/s13000-019-0863-8.","journal-title":"Diagnostic pathology"},{"issue":"7","key":"4732_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1872-034X.2008.00335.x","volume":"38","author":"Y Arakawa","year":"2008","unstructured":"Arakawa Y, Shimada M, Ikegami T, Kubo T, Imura S, Morine Y, et al. Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature. Hepatol Res. 2008;38(7):736\u201342. doi: https:\/\/doi.org\/10.1111\/j.1872-034X.2008.00335.x.","journal-title":"Hepatol Res"},{"issue":"2","key":"4732_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ags3.12016","volume":"1","author":"T Sumiyoshi","year":"2017","unstructured":"Sumiyoshi T, Shima Y, Okabayashi T, Ishikawa A, Matsumoto M, Iwata J, et al. Mucinous cholangiocarcinoma: Clinicopathological features of the rarest type of cholangiocarcinoma. Annals of gastroenterological surgery. 2017;1(2):114\u201321. doi: https:\/\/doi.org\/10.1002\/ags3.12016.","journal-title":"Annals of gastroenterological surgery"},{"key":"4732_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.humpath.2018.04.010","volume":"78","author":"Z Chi","year":"2018","unstructured":"Chi Z, Bhalla A, Saeed O, Cheng L, Curless K, Wang HL, et al. Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Human pathology. 2018;78:131\u20137. doi: https:\/\/doi.org\/10.1016\/j.humpath.2018.04.010.","journal-title":"Human pathology"},{"issue":"12","key":"4732_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","volume":"2","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World journal of hepatology. 2010;2(12):419\u201327. doi: https:\/\/doi.org\/10.4254\/wjh.v2.i12.419.","journal-title":"World journal of hepatology"},{"issue":"2","key":"4732_CR57","first-page":"125","volume":"87","author":"CN Yeh","year":"2002","unstructured":"Yeh CN, Jan YY, Chen MF. Adenosquamous carcinoma of the liver: clinicopathologic features in 12 patients and review of the literature. International surgery. 2002;87(2):125\u20139.","journal-title":"International surgery"},{"issue":"6","key":"4732_CR58","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/hep.24670","volume":"54","author":"J Bruix","year":"2011","unstructured":"Bruix J, Reig M, Rimola J, Forner A, Burrel M, Vilana R, Ayuso C. Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques. Hepatology. 2011;54(6):2238\u201344. doi: https:\/\/doi.org\/10.1002\/hep.24670.","journal-title":"Hepatology"},{"issue":"2","key":"4732_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2478\/raon-2021-0004","volume":"55","author":"JD Kovac","year":"2021","unstructured":"Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiology and oncology. 2021;55(2):130\u201343. doi: https:\/\/doi.org\/10.2478\/raon-2021-0004.","journal-title":"Radiology and oncology"},{"issue":"1","key":"4732_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00261-017-1196-2","volume":"43","author":"KJ Fowler","year":"2018","unstructured":"Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdominal radiology (New York). 2018;43(1):149\u201357. doi: https:\/\/doi.org\/10.1007\/s00261-017-1196-2.","journal-title":"Abdominal radiology (New York)"},{"key":"4732_CR61","doi-asserted-by":"crossref","unstructured":"Mejia JC, Pasko JJSC. Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. 2020;100(3):535\u201349.","DOI":"10.1016\/j.suc.2020.02.013"},{"key":"4732_CR62","doi-asserted-by":"crossref","unstructured":"Ye L, Schneider JS, Khaled NB, Schirmacher P, Seifert C, Frey L, et al. Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management. 2024;13(1):6.","DOI":"10.1159\/000530700"},{"issue":"7","key":"4732_CR63","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/cncr.10392","volume":"94","author":"WR Jarnagin","year":"2002","unstructured":"Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002;94(7):2040\u20136. doi: https:\/\/doi.org\/10.1002\/cncr.10392.","journal-title":"Cancer"},{"issue":"1","key":"4732_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hep.29789","volume":"68","author":"E Brunt","year":"2018","unstructured":"Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, et al. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology. 2018;68(1):113\u201326. doi: https:\/\/doi.org\/10.1002\/hep.29789.","journal-title":"Hepatology"},{"key":"4732_CR65","unstructured":"Theise N, Nakashima O, Park Y, Nakanuma Y, Bosman F, Garneiro F. WHO classification of tumours of the digestive system. Hepatocellular Carcinoma Bosman FT, Carneiro F, Hruban RH and Theise ND (eds) 4th edition IARC Press, Lyon. 2010:205\u2013\u200916."},{"issue":"2","key":"4732_CR66","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2214\/ajr.12.9488","volume":"201","author":"KJ Fowler","year":"2013","unstructured":"Fowler KJ, Sheybani A, Parker RA, 3rd, Doherty S, E MB, Chapman WC, Menias CO. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR American journal of roentgenology. 2013;201(2):332\u20139. doi: https:\/\/doi.org\/10.2214\/ajr.12.9488.","journal-title":"AJR American journal of roentgenology"},{"issue":"3","key":"4732_CR67","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1665-2681(19)30859-2","volume":"13","author":"K O\u2019Connor","year":"2014","unstructured":"O\u2019Connor K, Walsh JC, Schaeffer DF. Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity. Annals of hepatology. 2014;13(3):317\u201322.","journal-title":"Annals of hepatology"},{"issue":"9","key":"4732_CR68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature reviews Gastroenterology & hepatology. 2020;17(9):557\u201388. doi: https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nature reviews Gastroenterology & hepatology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04732-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T20:01:51Z","timestamp":1747080111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04732-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4732"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04732-8","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}